(1)
Clinical Evaluation of T-AYU-HM Premium in Sickle Cell Anemia Patients: A Retrospective Study. Int J Ayu Pharm Res 2022, 10 (Suppl2), 28-35. https://doi.org/10.47070/ijapr.v10iSuppl2.2554.